» Articles » PMID: 36452169

Identification of Risk Factors in Pre-term Infants with Abnormal General Movements

Overview
Journal Front Neurol
Specialty Neurology
Date 2022 Dec 1
PMID 36452169
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study aimed to investigate the relationship between prenatal, perinatal, and postnatal risk factors for neurodevelopmental impairment (NDI) with the outcomes of General Movement (GM) Assessment (GMA) in pre-term infants at 3-5 months of age. We sought to identify the risk factors associated with the predictors of psychomotor development in pre-term newborns, such as normal fidgety movements (FMs), absent FMs, or abnormal FMs, assessed during the fidgety period of motor development.

Methods: The SYNAGIS program (prophylactic of Respiratory Syncytial Virus Infection) was used to identify risk factors for the development of neuromotor deficits in 164 pre-term infants who were at high risk of developing these deficits. Based on the GMA, all participants were divided into three groups of infants who presented: (1) normal FMs; (2) absent FMs; and (3) abnormal FMs.

Results: The results of the current study suggest that abnormal GMs not only indicate commonly known factors like birth asphyxia (BA), respiratory distress syndrome (RDS), periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH) grades 3-4, but also predict the development of motor impairments. In the present study, several specific risk factors including bronchopulmonary dysplasia (BPD), infertility treatments, maternal acute viral/bacterial infections during pregnancy, and elevated bilirubin levels were identified as attributes of an atypical fidgety movement pattern.

Conclusions: Additional clinical data, such as risk factors for NDI associated with early predictors of psychomotor development in pre-term newborns, i.e., absent or abnormal FMs, may be helpful in predicting neurological outcomes in pre-term infants with developmental concerns in the 1st month of life.

Citing Articles

Placental pathology is associated with lower quality fidgety movements in preterm infants.

Abrudan A, Schoots M, Kooi E, Gordijn S, Kraft K, Prins J Pediatr Res. 2025; .

PMID: 39934646 DOI: 10.1038/s41390-025-03905-5.


Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring.

Prentice R, Hunt R, Spittle A, Ditchfield M, Chen J, Burns M Brain Behav Immun Health. 2024; 40:100827.

PMID: 39149622 PMC: 11326492. DOI: 10.1016/j.bbih.2024.100827.


The Relationship between General Movements and Risk Factors in Moderate-Late Preterm Infants: A Prospective Cohort Study.

Merino-Andres J, Perez-Nombela S, Hidalgo-Robles A, Perez-Dominguez M, Prieto-Sanchez L, Fernandez-Rego F J Clin Med. 2023; 12(24).

PMID: 38137832 PMC: 10743437. DOI: 10.3390/jcm12247763.

References
1.
van Iersel P, Bakker S, Jonker A, Hadders-Algra M . Quality of general movements in term infants with asphyxia. Early Hum Dev. 2008; 85(1):7-12. DOI: 10.1016/j.earlhumdev.2008.05.006. View

2.
Himpens E, Van Den Broeck C, Oostra A, Calders P, Vanhaesebrouck P . Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008; 50(5):334-40. DOI: 10.1111/j.1469-8749.2008.02047.x. View

3.
Smith D, Sagaram D, Miller R, Gyamfi-Bannerman C . Risk of cerebral palsy by gestational age among pregnancies at-risk for preterm birth. J Matern Fetal Neonatal Med. 2018; 33(12):2059-2063. DOI: 10.1080/14767058.2018.1536745. View

4.
Belfort M, Kuban K, OShea T, Allred E, Ehrenkranz R, Engelke S . Weight Status in the First 2 Years of Life and Neurodevelopmental Impairment in Extremely Low Gestational Age Newborns. J Pediatr. 2015; 168:30-35.e2. PMC: 4698026. DOI: 10.1016/j.jpeds.2015.09.036. View

5.
Linsell L, Malouf R, Morris J, Kurinczuk J, Marlow N . Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review. Dev Med Child Neurol. 2016; 58(6):554-69. PMC: 5321605. DOI: 10.1111/dmcn.12972. View